Fzata, Inc.
PrivateLast Round
Grant
Sep 24, 2024
Total Funding Raised
$25M
Company Overview
Fzata, Inc. is a biopharmaceutical company that develops oral live biotherapeutic medicines using its proprietary Bioengineered Probiotic Yeast Medicines (BioPYM™) platform to treat gastrointestinal and gut-brain axis disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fzata, Inc. Comparables
Compare Fzata, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Esperovax | 80% | |
| Precigen | 78% | |
| Sorriso Therapeutics | 76% | |
Fzata, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 24, 2024 | ||||
| Series A | Jan 26, 2023 | ||||
| Grant | Jan 15, 2018 |
Fzata, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| TEDCO | Seed |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2024
$7M grant awarded by NINDS
- Mar 28, 2024
Grew 38% QoQ, from 8 to 11 employees.
Fzata, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Fzata, Inc.'s valuation, stock price, and market status.